Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-24-119802
Filing Date
2024-11-01
Accepted
2024-11-01 07:08:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3400
  Complete submission text file 0000950170-24-119802.txt   5023
Mailing Address 9301 AMBERGLEN BOULEVARD, SUITE 100 C/O MOLECULAR TEMPLATES, INC. AUSTIN TX 78729
Business Address
Cutler Adam D. (Reporting) CIK: 0001722673 (see all company filings)

Type: 144

Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Subject) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41837 | Film No.: 241417044
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)